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Résumé Summary
Face à la publicité de médicaments, que pouvons-nous?
Est-ce que la publicité directes au consommateur (DTCA)
est bienfaisant à notre égard en présentant de façon
objective un produit ou cherche-t-elle à nous convaincre
que c’est définitivement le bon traitement, la bonne
approche, pour nous soigner? À travers cette chanson, le
but est de faire vivre l’expérience d’un patient qui est sujet
à de la publicité, en intégrant dans les strophes les
principaux enjeux éthiques que cela soulève.
In the face of drugs advertising, what can we do? Is Direct-
to-Consumer Advertising (DTCA) designed to be beneficial
by objectively presenting a product or are they rather
seeking to convince us that their product is patently good?
Through this song, the goal is to live the experience of a
patient who is subject to drug advertising, by integrating
into the stanzas the main ethical issues raised by
advertising.
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It’s just one, in a million minds,
that feel the way, the way I do.
It’s just one, in a million minds, 
that feel the way, the way I do.
Am I the wrong man, am I not of great merit?
Do I feel care like all of the others or is this feeling only mine?
Are you my relieving cure? Is it an obvious claim?
I’m living like a lion pretending I’m healthy but we know it’s only a big lie.
Am I one heartbeat away from receiving a redemptive speech to my health and believing that care
was a cause praiseworthy while seeing it’s all part of a scheme? 
Fighting is futile, but I can’t concede, while interior beliefs alert me of their corporate deceitful
practices which have grown from a relentless pursuit for profit.
We’re vuln’rable, we can’t think through;
Faith in their meds, as in their ads.
A poison’s brain, pass through my mind.
Look at the frame, around the lie.
Trust has a form, too convincing;
I need defence, against their claims.
We can’t go far, we know nothing,
About their meds, about their lust.
It’s just one, in a million minds, 
that suffers the way, the way I do.
It’s just one, in a million minds, 
that suffers the way, the way I do.
Epilogue
As I was listening to the song “Her Fantasy” by Matthew Dear1 while working on my thesis, I got
carried away by the music and I started to associate the metaphors of the search for love and the
game of seduction in the song to my doctoral area of research: direct-to-consumer communications
(DTCC) of prescription drugs. It seemed to me that Dear’s song allowed me to draw interesting
parallels with DTCC, especially in relation to the ethical issues surrounding DTCC. To achieve this, I
preserved the song’s structure, and the idea of a banal main character who could be anyone (not
unhealthy per se, but neither a paragon of healthy lifestyles), while reworking the text so that it evokes
and presents my doctoral research problem, all along maintaining decent adequacy with the melody. 
The ethics of direct communications from pharmaceutical companies to consumers is a particularly
relevant theme given that DTCA can affect virtually all patients in every country, in one way or
another, thus raising its share of ethical issues. Despite the variability of national health policies on
DTCC and the degree of regulatory permissiveness, at least one type of communication is permitted
in each country: either under a promotional or informational form. And most often, DTCC uses mass
media thus ensuring that such messages can easily reach patients. DTCC includes two large families
of communications to patients: DTC advertising (DTCA) and DTC information (DTCI). For instance, in
the most DTCC permissive countries (i.e., the US and New Zealand), consumers will be subjected to
DTCA, such as TV commercials presenting the merits of a certain product [1]. But consumers in
countries that do not allow DTCA may still be subject to DTCI campaigns sponsored by
pharmaceutical companies. For example, campaigns in Canada, the United Kingdom or the
Netherlands may be televised, in-print or on the web with the aim of “raising awareness” for a
1 Matthew Dear, “Her Fantasy”, Label: Ghostly International – GI-156. Released June 4, 2012.
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particular disease [1,2]. With the advent of new media and social networks, DTCI and DTCA are now
available far beyond the borders of permissive countries, reaching out to a larger audience than the
local population [3]. Finally, the “direct” aspect pharmaceutically-sponsored communication reaches
its zenith with in-person activities, taking place in non-clinical environments such as in restaurants,
during which patients and pharmaceutical representatives mingle [4].
In this new song, Dear’s core theme of love-seeking has been replaced by the fundamental issues of
DTCA: patients’ strong desire to have access to treatments that will relieve their symptoms and ideally
cure them; their vulnerabilities when it comes to assessing commercial claims about certain products
that may appear to either be miraculous, or specifically intended for them, due to informational
asymmetry that favours companies over patients [5]; and the limited extent to which the informational
aspect of DTCC really empowers patients when it may actually have the inverse effect of convincing
them that a certain product is the solution to their health concerns [1,6]. While these issues can be
discussed extensively and thoroughly in the scientific literature, their presentation in a song can help
to give substance and clarity in order to enable understanding of their nature and extent, as well as to
raise awareness about the pervasive effect of DTCC. Thus, the reader will be able to understand that
DTCC may not have so much an informational purpose, but rather a promotional one in relation to a
given product, and that motivations other than “care” are underlying such messages. In the song,
DTCC is mainly presented through televised DTCA with references to frames that can refer to both
the contours of a television and the images presented.
Hence, Dear’s game of seduction is kindred to the promotional endeavour: both try to seduce by
presenting a person with what s/he desires and fantasizes. The search for love by the former main
character in Dear’s song is analogous to the quest for “care” by a patient2, the latter confusing the
actual purpose of advertisements (increasing a product’s sales) with what is needed (search for an
effective treatment) [1].
Afterword
The re-work of Dear’s song is part of a genuine creative process in which, importantly, the re-
appropriation remains transparent and unambiguous. To acknowledge that fact, the title is a tribute to
the original song: both the author’s family name (Dear) and part of the title (by reusing the word
“fantasy”) have been included. This song arises from a real moment of creative joy in juggling with
words and of restricting myself into a strict writing form, so as to create a new object – somewhat
hybridized between research and art – evoking the sensitive side of my doctoral topic by the
personification and the staging of ethical issues, while retaining rigour in the process and the final
result.
Using arts to raise awareness about certain research results is an interesting way to push further their
accessibility by presenting research in a more convenient and appealing format, shape, length and
tone. We could therefore argue that art-based knowledge transfer (ABKT) allows the presentation of a
complex issue without the need of scientific formalism. Performing ABKT requires a genuine creative
process, so that the end-product (in this case, the song) as well as the intention are not
instrumentalizing. In this context, the intention in the current work was not to claim that arts should be
used for illustrating ethics; but rather that the arts have a much more important contribution, and one
that is genuine and distinct [7]. The arts may even be a new way to perform research results by
making the reader (or listener, if by chance this adaption of Dear’s song were ever recorded) live the
problem at stake through the aesthetics of the lyrics, and by presenting the issue with simplicity, and
with some candor; something that is probably only possible for an object outside the formalism
imposed by conventional scientific publication. The song is not only a means among others to
disseminate the production of knowledge, it is also a unique way to experience the challenges of
sharing knowledge by emphasizing the sensitive side of the rational.
2 We could even add that it is analogous to biomedical research’s quest for a cure, which is often performed through the
search for a single drug to treat/cure patients, and seen as more desirable than other types of treatments.
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